Mr David Norman Gilbert, MD | |
5050 Ne Hoyt St, Ste 540, Portland, OR 97213-2985 | |
(503) 215-6601 | |
(503) 215-6857 |
Full Name | Mr David Norman Gilbert |
---|---|
Gender | Male |
Speciality | Internal Medicine - Infectious Disease |
Location | 5050 Ne Hoyt St, Portland, Oregon |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1578569257 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RI0200X | Internal Medicine - Infectious Disease | MD06931 (Oregon) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr David Norman Gilbert, MD Po Box 3158, Portland, OR 97208-3158 Ph: (503) 215-6494 | Mr David Norman Gilbert, MD 5050 Ne Hoyt St, Ste 540, Portland, OR 97213-2985 Ph: (503) 215-6601 |
News Archive
Men with a high genetic risk of developing bowel cancer over the next 25 years could have a lower risk of developing the disease if they also have a healthy lifestyle, according to a Cancer Research UK-funded study published in the journal Genetics in Medicine today (Thursday).
InteKrin Therapeutics Inc. announced today it will present 6 month Phase 2b clinical data for edema in diabetic patients showing differentiation for INT131, a Selective PPAR-gamma Modulator (SPPARM), from Actos® pioglitazone, at the American Diabetes Association annual meeting in Orlando, FL, Monday, June 28, 2010 at 2:45 pm EDT during the "Update on BARI 2D -Treatment of Insulin Resistance" session.
The National Institute on Drug Abuse has awarded a $2.1 million contract to Perlegen Sciences, Inc., to investigate the human genome for DNA variations and candidate genes associated with nicotine addiction.
The EU-funded GENEPI project will provide the facility for essential research which will improve and refine radiotherapy for European cancer patients
As announced on August 11, 2014, Twinlab Consolidation Corporation completed its first transaction with the acquisition of Twinlab Corporation. Today, TCC announces the successful completion of its merger into Twinlab Consolidated Holdings Inc., resulting in TCC becoming a wholly-owned subsidiary of TLCC.
› Verified 6 days ago
Salona Shrestha, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 4805 Ne Glisan St, Portland, OR 97213 Phone: 503-215-2392 | |
Dr. Emmanuel Trungtoan Tavan, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 2800 N Vancouver Ave, Suite 230, Portland, OR 97227 Phone: 503-413-2901 | |
Ginevra Lois Liptan, M.D. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 6400 Sw Canyon Ct, Ste 100, Portland, OR 97221 Phone: 503-477-9616 Fax: 503-477-9808 | |
Donald Richard Sullivan, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 3181 Sw Sam Jackson Park Rd, Uhn67, Portland, OR 97239 Phone: 503-494-6949 | |
Dr. Victor Nguyen Pham, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 9205 Sw Barnes Rd, Portland, OR 97225 Phone: 503-216-2906 | |
Richa Uppal, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 800 Sw 13th Ave, Portland, OR 97205 Phone: 503-221-0161 Fax: 503-274-1697 | |
Reem Hasan, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 3181 Sw Sam Jackson Park Rd, Ppv 350, Portland, OR 97239 Phone: 503-494-8562 |